Fast Identification of Omicron Spread Through Wastewater Monitoring in Denmark, and Strong Cooperation Between Eurofins and Statens Serum Institut (SSI, Danish Health Authorities) Has Enabled Prompt Action Against the Pandemic
07 Décembre 2021 - 3:03PM
Business Wire
For a number of months now, Eurofins Scientific (Paris:ERF) has
been monitoring wastewater in Denmark for the presence of
SARS-CoV-2, through the regular (3 times per week) sampling of
around 200 wastewater treatment plants across the country.
Wastewater is an effective mirror of society, and wastewater
testing is acknowledged as a way to monitor the virus’ spread and
to detect new variants early, often before the first clinical cases
are known.
On 1st December 2021, as part of the national surveillance
programme, Eurofins received the regularly planned wastewater
samples to be tested for the presence of SARS-CoV-2. In parallel,
80 samples were also tested through the Eurofins VIRType™
SARS-CoV-2 (L452R) and VIRType™ SARS-CoV-2 (K417N) kits, to
potentially identify the presence of the Delta and Omicron
variants, through rapid detection of single point K417N and L452R
mutations respectively.
On 2nd December, 3 of these wastewater samples tested positive
for the mutation K417N, indicating the likely presence of
Omicron.
SSI was immediately informed, and the 3 positive samples shipped
to them for confirmation through NGS sequencing. On 3rd December,
the presence of Omicron was confirmed, providing the Danish
authorities with very early warning of the presence of the new
variant and allowing them to take the necessary measures rapidly.
The first known human case of Omicron in Denmark was found on 27th
November.
Scientific innovation, testing capacity and very close
cooperation between Eurofins and the Danish authorities has enabled
a fast response and targeted management of the pandemic.
Eurofins continues to innovate and make such services available
to health authorities in many countries in Europe and beyond.
Notes to Editors:
For more information, please visit www.eurofins.com
About Eurofins – the global leader in bio-analysis
Eurofins is Testing for Life. With 55,000 staff across a network
of 900 laboratories in over 50 countries, Eurofins’ companies offer
a portfolio of over 200,000 analytical methods.
Eurofins Shares are listed on Euronext Paris Stock Exchange.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211207005711/en/
Investor Relations Eurofins Scientific SE Jesper Gamst Phone:
+32 2 766 1620 E-mail: ir@eurofins.com
Eurofins Scientific (EU:ERF)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
Eurofins Scientific (EU:ERF)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024
